MENU
CURX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Curanex Pharmaceuticals (CURX) Ownership - Who owns Curanex Pharmaceuticals?

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.41M
P/E Ratio
N/A
Total Cash
5.83M
Projected Growth
N/A
Total Debt
61.15K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CURX
Capitalization
9.42M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
5.83M
Total Cash/Share
0.21
Total Debt
61.2K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
14.3M
P/B Ratio
0.66
Cash Flow
N/A
Earnings
-0.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.83K
Current Ratio
77.53
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-1.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.16
Shares Held By Institutions
215K
Shares Outstanding - Current
28.3M
Total Liabilities
186K
Total Volume MTD
N/A
Value
1
Gain YTD
0.484
View a ticker or compare two or three
CURX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details